Ipamorelin
Also known as: IPAM, growth hormone secretagogue
Research on ipamorelin, a selective growth hormone secretagogue peptide, in pituitary signaling and metabolic studies.
What does the research say about Ipamorelin?
Ipamorelin stimulates GH release with comparatively selective receptor activity in preclinical and early clinical models. Literature spans endocrine physiology and sport-science adjacent cohorts.
Synapse surfaces peer-reviewed research and researcher networks for informational purposes only. This page does not provide medical advice, dosing guidance, or treatment recommendations.
Research feed: Ipamorelin
11 indexed papers matched to curated MeSH concepts in the last 90 days.
Research Peptides for Sale: Quality Standards for BPC-157, TB-500, Sermorelin and Epitalon Procurement
Technical review outlines quality verification standards for research peptides, suggesting improved procurement processes.
A Unified API-Driven IPAM Framework with LSTM-Based Anomaly Detection for Hybrid Cloud Environments
Randomized trial demonstrates enhanced IP address management and anomaly detection in hybrid cloud environments, suggesting significant improvements.
Dopamine D2 Receptor Isoform Heteroreceptor Complexes with the Growth Hormone Secretagogue Receptor 1a Reveals Isoform-Specific Interaction Interface Dynamics
Computational analysis reveals isoform-specific interactions in G-protein-coupled receptor complexes influencing neurodegenerative disorders.
Therapeutic peptides in gerontology: mechanisms and applications for healthy aging
Background: Peptide therapeutics represent an emerging frontier in gerontological medicine, targeting fundamental hallmarks of aging including metabolic dysfunction, telomere attrition, tissue repair impairment, and hormonal decline. Objective: To comprehensively review the mechanisms, clinical applications, evidence base, and safety profiles of therapeutic peptides with demonstrated or potential applications in healthy aging and age-related conditions. Methods: A comprehensive narrative review was conducted through systematic searches of PubMed, Scopus, and regulatory databases (FDA, WADA) from inception through January 2026. Search terms included "peptide therapeutics," "aging," "gerontology," "healthspan," combined with specific peptide names (tirzepatide, epitalon, GHK-Cu, BPC-157, TB-500, Semax, CJC-1295, ipamorelin, bremelanotide). Peer-reviewed articles, clinical trials, regulatory documents, and preclinical studies were evaluated. A total of 20 primary sources were selected based on relevance, methodological quality, and contribution to understanding peptide mechanisms and clinical outcomes in aging populations. Results: Nine peptides were identified spanning diverse aging interventions: metabolic restoration (tirzepatide), telomere biology (epitalon), dermal regeneration (GHK-Cu), tissue repair (BPC-157, TB-500), neuroprotection (Semax), growth hormone modulation (CJC-1295, ipamorelin), and sexual function (bremelanotide). FDA-approved agents demonstrated robust safety profiles from large-scale trials. Non-approved peptides showed promising preclinical and limited clinical evidence but lack long-term safety data and systematic validation. Significant knowledge gaps include optimal dosing regimens, combination therapy effects, and biomarkers for monitoring efficacy. Conclusion: Therapeutic peptides offer mechanistically diverse approaches to multiple aging hallmarks. While FDA-approved agents demonstrate clinical potential, investigational peptides require rigorous validation through well-designed clinical trials to establish safety and efficacy for healthspan extension.
Abstract Number: Esoc2026a944 Microglial Catabolic Defect of Branched-Chain Amino Acids Promotes Post-Stroke Neuroinflammation and Acute Ischemic Brain Injury
Randomized trial investigates microglial BCAA catabolism's role in neuroinflammation and ischemic injury, indicating a new therapeutic target.
Can long-acting growth hormone improve adherence in pediatric growth hormone deficiency?
Narrative review summarizes adherence to long-acting growth hormone in children with growth hormone deficiency, suggesting gaps in evidence.
A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical review
Critical review examines peptide drugs' effects in sport, highlighting risks for recreational and professional athletes.
Human iPSC-derived alveolar macrophages reveal macrophage subtype functions of itaconate in M. tuberculosis defense
Investigation reveals itaconate's distinct effects in macrophage subtypes during M. tuberculosis defense, suggesting new pathways for treatment.
Regulation of Paracellular Permeability by Secretagogues in Parotid Acinar Cells
Investigation of paracellular permeability changes in cultured acinar cells, highlighting secretagogue roles.
Injectable Peptides in Sports Medicine: A Structured Narrative Review of Evidence, Safety, and Antidoping Implications
Structured narrative review summarizes injectable peptides' evidence, safety, and antidoping implications in sports medicine.
Researchers studying Ipamorelin
Researcher network data is loading or unavailable for this topic.
Follow Ipamorelin literature with AI-enriched clinical evidence on Synapse.
Search Ipamorelin on SynapsePowered by Synapse — AI-enriched analysis of 600,000+ peer-reviewed papers